Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN) is a leading computational biology company targeting to revolutionize life-science product development.
INVESTOR RELATIONS CONTACT
Rivka Neufeld/Aviva Banczewski | Investor Relations Manager
Upcoming events
Evogene Financial Results and Earnings Announcement for the Fourth Quarter and Full Year of 2020
February 17, 2021